share_log

Pancreatic Cancer Action Network Urges Advocates From All 50 States To Call On Congress To Increase Federal Funding For Pancreatic Cancer Research

Pancreatic Cancer Action Network Urges Advocates From All 50 States To Call On Congress To Increase Federal Funding For Pancreatic Cancer Research

胰腺癌行動網絡敦促來自所有50個州的倡導者呼籲國會增加聯邦對胰腺癌研究的資助
Benzinga ·  2023/06/14 21:13

Federal Funding Increases Fuel Research Progress and Help Improve Patient Outcomes

聯邦撥款推動研究進展,幫助改善患者預後

LOS ANGELES, June 14, 2023 /PRNewswire/ -- The Pancreatic Cancer Action Network (PanCAN), a leading pancreatic cancer patient advocacy organization, today launched its Call on Congress Day campaign, part of its annual advocacy strategy to mobilize pancreatic cancer survivors, caregivers and supporters from around the United States to urge their members of Congress to increase the federal research investment for the world's deadliest cancer. This year, advocates are asking Congress to increase the investment in the dedicated Pancreatic Cancer Research Program at the Department of Defense (DOD) from $15 to $20 million and secure $50.924 billion for the National Institutes of Health (NIH) base budget, including $9.988 billion for the National Cancer Institute (NCI).

洛杉磯,2023年6月14日 /PRNewswire/--領先的胰腺癌患者倡導組織胰腺癌行動網絡(panCan)今天啓動了國會日呼籲活動,這是其年度宣傳戰略的一部分,旨在動員來自美國各地的胰腺癌倖存者、護理人員和支持者,敦促其國會議員增加對世界上最致命的癌症的聯邦研究投資。今年,倡導者要求國會將國防部(DOD)專門的胰腺癌研究計劃的投資從1500萬美元增加到2000萬美元,併爲美國國立衛生研究院(NIH)的基本預算提供509.24億美元,其中包括美國國家癌症研究所(NCI)的99.88億美元。

Pancreatic cancer is the world's toughest cancer and is on track to become the second leading cause of cancer-related death in the United States. It demands urgent action to save lives. Given few effective treatments and no standard early detection test, research funding continues to be critical in the fight against this challenging disease -- and approximately 80% of funding comes from the federal government, highlighting the importance of the efforts of PanCAN and its advocates.

胰腺癌是世界上最嚴重的癌症,有望成爲美國第二大癌症相關死亡原因。它要求採取緊急行動來拯救生命。鑑於有效的治療方法很少,也沒有標準的早期發現測試,研究資金對於抗擊這種具有挑戰性的疾病仍然至關重要,大約80%的資金來自聯邦政府,這凸顯了panCan及其倡導者努力的重要性。

"While the political discourse in this country often continues to be divided down party lines, increasing federal research investment for deadly diseases like pancreatic cancer is a bipartisan issue and we're grateful to have champions in Congress on both sides of the aisle," said Julie Fleshman, JD, MBA, president and CEO of PanCAN. "Pancreatic cancer does not discriminate. We urge Congress to make this vital research a priority in order to fuel progress and improve outcomes for patients."

panCan總裁兼首席執行官Julie Fleshman表示:“儘管這個國家的政治話語經常繼續按黨派分歧,但增加對胰腺癌等致命疾病的聯邦研究投資是一個兩黨的問題,我們很感激國會兩邊都有擁護者。”“胰腺癌不分青紅皁白。我們敦促國會將這項重要研究作爲優先事項,以推動進展並改善患者的預後。”

To demonstrate how simple it is to take action by calling members of Congress to make these asks, Star Trek actress, 19-year pancreatic cancer survivor, and PanCAN advocate, Kitty Swink, recorded herself making calls to the offices of her three members of Congress. The videos, shared on PanCAN social media, encourage other advocates to join the movement and make their voices heard. Also, for the first time this year, advocates can join a virtual PanCAN Action Chat to make calls to Congress in community with one another, connecting their passion and actions as a united group.

爲了證明通過召集國會議員提出這些要求來採取行動是多麼簡單,《星際迷航》女演員、19年的胰腺癌倖存者、PanCan倡導者凱蒂·斯溫克記錄了自己打電話給三位國會議員辦公室的情況。這些視頻在panCan社交媒體上分享,鼓勵其他倡導者加入該運動並表達自己的聲音。此外,倡導者今年首次可以加入虛擬的panCan Action Chat,在社區中與國會打電話,將他們作爲一個團結的團體的激情和行動聯繫起來。

Thanks to PanCAN and its advocates, the federal research investment in pancreatic cancer at the NCI has steadily grown over the last two decades. In 1999, when PanCAN was founded, the investment was just $17.7 million. By 2018 (the latest data available), it had grown to $182.1 million. This funding has had a significant impact on the five-year pancreatic cancer survival rate which increased from just 4% in 1999 to 12% this year. PanCAN and its advocates have an ambitious goal of increasing the five-year survival rate to 20% by 2030.

多虧了panCan及其倡導者,NCI對胰腺癌的聯邦研究投資在過去二十年中穩步增長。1999年,當panCan成立時,投資僅爲1770萬美元。到2018年(現有的最新數據),它已增長到1.821億美元。這筆資金對胰腺癌的五年存活率產生了重大影響,該存活率從1999年的僅4%提高到今年的12%。panCan及其倡導者有一個雄心勃勃的目標,即到2030年將五年存活率提高到20%。

To learn how to Call on Congress today to accelerate progress, go to pancan.org/calloncongressday.

要了解如何立即呼籲國會加快進展,請訪問 pancan.org/calloncongressday。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論